"MyPlan" - Individualized Planned Eating Patterns for Adolescents With Type 1 Diabetes
NCT05147324 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52
Last updated 2024-04-23
Summary
The purpose of this study is to test the acceptability and effectiveness of an individualized eating strategy as part of diabetes self-management to improve glycemic levels among youth with type 1 diabetes (T1D) and suboptimal glycemic management. Investigators will assess participant acceptability of and adherence to a 6-month individualized eating strategy ("MyPlan") characterized by approximate day-to-day consistency in the frequency and timing of meals and snacks and distribution of carbohydrate throughout the day. Within-individual change in glycemic levels between baseline and 6-months of the study will also be compared. The goal of the study is to inform the design of a future randomized clinical trial to test the addition of the MyPlan eating strategy to ongoing diabetes clinical care among youth with T1D.
Conditions
Interventions
- BEHAVIORAL
-
"MyPlan" - Individualized Planned Eating Pattern
Sessions involve a structured behavior change counseling module derived from FLEX (NCT01286350), DASH-4-Teens (NCT00585832), and a Social Cognitive Theory and Transtheoretical Model informed conceptual framework, which uses education, motivation and self-efficacy enhancement, goal setting, and problem-solving skills training to initiate and sustain eating pattern adherence. Sessions support incremental progress towards meeting all five eating behavior goals by helping youth develop action plans, troubleshoot barriers to adherence, and refine action plans to improve adherence. Youth log in MyFitnessPal at least three days per week. Logs are used to assess and troubleshoot adherence, support youth in developing and refining action plans, and reward youth with points. Incentives are allocated using a point scheme designed to promote logging and goal achievement. Formal adjustment of the eating pattern is based on adherence according to logs and youth/guardian acceptability.
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH -
University of Cincinnati
collaborator OTHER -
University of North Carolina, Chapel Hill
lead OTHER
Principal Investigators
-
Elizabeth J Mayer-Davis, PhD · University of North Carolina, Chapel Hill
-
Sarah Couch, PhD · University of Cincinnati
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 12 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-13
- Primary Completion
- 2023-04-24
- Completion
- 2023-04-24
Countries
- United States
Study Locations
More Related Trials
-
A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus
NCT04157738 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Effects of Carbohydrate Counting
NCT01223547 ·Status: COMPLETED ·Phase: NA
-
The Steno Opti-Bolus-Timing Studies
NCT07021690 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Insulin Exposure and Glucose Response to Meals in Type 1 Diabetic Subjects Administered Two Different Insulin Regimens Compared to the Endogenous Insulin Exposure and Glucose Response to Meals In Healthy Adult Controls
NCT00927524 ·Status: COMPLETED ·Phase: NA
-
Timing of Pre-meal Insulin Versus Accurate Carbohydrate Counting in Youth With Type 1 Diabetes
NCT01209312 ·Status: COMPLETED ·Phase: NA
-
The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins
NCT00313742 ·Status: COMPLETED ·Phase: PHASE4
-
Time Limited Eating in Type 1 Diabetes
NCT05031429 ·Status: COMPLETED ·Phase: NA
-
The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
NCT00529165 ·Status: COMPLETED ·Phase: NA
-
Timing of Insulin Before Meals Everyday
NCT00789945 ·Status: TERMINATED ·Phase: NA
-
Carb Counting vs. Simplified Qualitative Meal-Size Estimation
NCT06687434 ·Status: RECRUITING ·Phase: NA
-
Effects of a Remote Patient Monitoring Protocol on Glycemic Control in Adolescents With Type 1 Diabetes
NCT03466398 ·Status: WITHDRAWN ·Phase: NA
-
Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus
NCT02514954 ·Status: COMPLETED ·Phase: PHASE1
-
Reducing the Risk of Metabolic Decompensation in Diabetic Adolescents by Supervised School Administration of Insulin
NCT03400501 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia
NCT02411578 ·Status: COMPLETED ·Phase: PHASE2
-
Simple Meal Management Using Automated Insulin Delivery System
NCT06130215 ·Status: RECRUITING ·Phase: NA
-
Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating
NCT00553488 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes
NCT01769404 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
NCT00419562 ·Status: COMPLETED ·Phase: PHASE3
-
Lunch Time Insulin Injection by School Nurse for Poorly Controlled Diabetes
NCT00340613 ·Status: COMPLETED ·Phase: PHASE4
-
Carbohydrate Count Aided by a Simulation in People With Type 1 Diabetes Mellitus. A Protocol for a Clinical Trial
NCT05181917 ·Status: COMPLETED ·Phase: NA
-
Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes
NCT04764968 ·Status: COMPLETED ·Phase: PHASE2
-
Timing of Meal Insulin Boluses for Optimal Postprandial Glycemic Control in Type 1 Diabetes
NCT01693302 ·Status: COMPLETED ·Phase: NA
-
Insulin Bolus Required for High Fat Foods in Type 1 Diabetes
NCT02248454 ·Status: COMPLETED ·Phase: NA
-
Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents
NCT02402933 ·Status: COMPLETED ·Phase: PHASE3
-
Optimizing Metabolic Control in Type 1 Diabetes - The Automatic Bolus Calculator Flash Study
NCT03682237 ·Status: COMPLETED ·Phase: NA